Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation

OBJECTIVE(S): Recently, bone-avid radiopharmaceuticals have been shown to have potential benefits for the treatment of widespread bone metastases. Although (177)Lu-triethylene tetramine hexa methylene phosphonic acid (abbreviated as (177)Lu-TTHMP), as an agent for bone pain palliation, has been eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Zolghadri, Samaneh, Yousefnia, Hassan, Jalilian, Amir Reza, Ghannadi-Maragheh, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Oceania Journal of Nuclear Medicine & Biology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937688/
https://www.ncbi.nlm.nih.gov/pubmed/27408879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937688/
https://www.ncbi.nlm.nih.gov/pubmed/27408879

Ejemplares similares